Navigation Links
Patheon-Sponsored Event to Highlight “Product Enhancement Through Complex Dosage Forms: Adding Value to Products’ Lifecycle Management”
Date:6/5/2013

(PRWEB) June 05, 2013

Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, is hosting a complimentary, half-day seminar on “Product Enhancement through Complex Dosage Forms: Adding Value to Products’ Lifecycle Management” on June 18, 2013 at the MassBio Headquarters in Cambridge, Massachusetts.

Complex dosage forms provide novel business opportunities for companies to leverage their existing products and intellectual property. Pharmaceutical industry experts will discuss several life cycle management strategies to enhance the product life cycle and extend the life of a drug.

Topics covered, but not limited to, include:

  • How to enhance existing product portfolio
  • How to improve and register existing marketed products
  • How to get a product to the market, including regulatory filing and approval requirements for complex dosage forms
  • Challenges for a sterile solution that requires lyophilization in order to meet commercial stability requirements
  • Drug formulation considerations in order to get a lyophilized product commercialized

Presentations will be provided by Patheon employees, Anil Kane, Ph.D., MBA, Executive Director, Global PDS Formulation Sciences, and Don Barbieri, Associate Director of Formulation and Process Development, as well as by Doug Stockdale, MBA, Life Sciences Executive, and John McCarty, Consultant with Pharmaceutical Productions.    

Visit the company’s website at http://www.patheon.com/Knowledge-Library/Events.aspx to learn more or register for the upcoming seminar. Seating is limited.

About Patheon

Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule technology – Patheon now also includes a proprietary products and technology business.

Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated network consists of 17 locations, including 13 commercial contract manufacturing facilities and 12 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit http://www.patheon.com.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10789471.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Dr. Louis Amendolagine and Dr. Geri Friefeld Launch a Ground Breaking Cavity Prevention Program That Lowers Decay Rates by 74%
2. Dr. Althauser Launches Ground-breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
3. Health Diagnostic Laboratory, Inc.s new Diabetes Prevention & Management Panel incorporates discovery from Metabolon researchers
4. Brookfield Dental Care Launches Ground-breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
5. Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches
6. Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It
7. Probiotic Action The “Best Acne Treatment” Shares New Insight on the Future of Preventing the Spread of Acne Causing Germs
8. A Media Event on Clinical Developments in Gene and Cell Therapy
9. BioConvergence® Celebrates Seventh Anniversary as a Life Sciences Contract Service Provider
10. Marshfield Dentist Launches Groundbreaking Cavity Prevention Program That Can Lower Tooth Decay Rates by 74 Percent
11. Dentistry at Somerset Launches Ground Breaking Cavity Prevention Program That Can Lower Decay Rates by 74%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016  Regular discussions on a range of subjects ... the two entities said Poloz. Speaking at a ... , he pointed to the country,s inflation target, which ... "In certain areas ... have common economic goals, why not sit down and address ...
(Date:6/24/2016)... ... 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers use ... 6000i models are higher end machines that use the more unconventional z-dimension of 20mm. ... from the bottom of the cuvette holder. , FireflySci has developed several Agilent ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, a ... eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical research ... by providing practical tips, tools, and strategies for clinical researchers. , “The landscape ...
(Date:6/23/2016)...   Boston Biomedical , an industry leader ... target cancer stemness pathways, announced that its lead ... Designation from the U.S. Food and Drug Administration ... gastroesophageal junction (GEJ) cancer. Napabucasin is an orally ... stemness pathways by targeting STAT3, and is currently ...
Breaking Biology Technology:
(Date:6/9/2016)... TURKU, Finland , June 9, 2016 ... French National Police deploy Teleste,s video security solution to ensure ... France during the major tournament ... and data communications systems and services, announced today that its ... Police Prefecture to back up public safety across ...
(Date:6/2/2016)... --  The Weather Company , an IBM Business (NYSE: ... in which consumers will be able to interact with IBM ... voice or text and receive relevant information about the product ... have long sought an advertising solution that can create a ... and valuable; and can scale across millions of interactions and ...
(Date:5/20/2016)... , May 20, 2016  VoiceIt is excited ... with VoicePass. By working together, VoiceIt ...  Because VoiceIt and VoicePass take slightly different approaches ... increases both security and usability. ... about this new partnership. "This marketing ...
Breaking Biology News(10 mins):